Monopar Therapeutics Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2015 | — | $2.8M | $2.8M |
| Dec 2016 | — | $2.8M | $2.1M |
| Mar 2017 | — | — | $3.6M |
| Jun 2017 | — | — | $4.3M |
| Sep 2017 | — | — | $10.6M |
| Dec 2017 | — | $9.6M | $9.0M |
| Mar 2018 | — | $8.9M | $8.2M |
| Jun 2018 | — | $8.1M | $7.4M |
| Sep 2018 | — | $7.6M | $7.6M |
| Dec 2018 | — | $6.9M | $6.9M |
| Mar 2019 | — | $5.8M | $5.9M |
| Jun 2019 | — | $5.1M | $5.1M |
| Sep 2019 | — | $4.6M | $4.5M |
| Dec 2019 | — | $12.6M | $13.2M |
| Mar 2020 | — | $12.4M | $12.6M |
| Jun 2020 | — | $12.2M | $12.5M |
| Sep 2020 | — | $17.5M | $18.0M |
| Dec 2020 | — | $15.7M | $16.7M |
| Mar 2021 | — | $25.1M | $25.7M |
| Jun 2021 | — | $23.4M | $24.3M |
| Sep 2021 | — | $21.3M | $22.3M |
| Dec 2021 | — | $18.9M | $20.3M |
| Mar 2022 | — | $17.0M | $17.8M |
| Jun 2022 | — | $14.5M | $16.5M |
| Sep 2022 | — | $12.5M | $14.3M |
| Dec 2022 | — | $10.1M | $8.2M |
| Mar 2023 | — | $8.9M | $5.7M |
| Jun 2023 | — | $7.8M | $7.2M |
| Sep 2023 | — | $6.6M | $5.5M |
| Dec 2023 | — | $5.6M | $7.3M |
| Mar 2024 | — | $7.5M | $7.8M |
| Jun 2024 | — | $6.1M | $6.1M |
| Sep 2024 | — | $4.9M | $6.0M |
| Dec 2024 | — | $55.0M | $45.8M |
| Mar 2025 | — | $53.6M | $39.7M |
| Jun 2025 | — | $52.2M | $39.5M |
| Sep 2025 | — | $141.6M | $127.7M |
| Dec 2025 | — | $137.8M | $61.8M |
| Mar 2026 | — | $135.4M | $52.5M |
| Jun 2026 | — | $130.9M | $52.8M |